Dosimetric Methods

Measurement of Absorbed Dose
The choice of a particular type of dosimeter depends on a number of factors such as the accuracy of the absorbed dose determination required, the sensitivity of the system, and the neutron energy dependence. Also, the size of the dosimeter and the processing of the response may be important. At present, the use of a tissue-equivalent (TE) calorimeter probably gives the smallest uncertainty in the determination of total absorbed dose in a neutron field (McDonald et al., 1981a, b; Caumes et al., 1984) . As discussed in ICRU Report 26 (ICRU, 1977) the method is, however, too cumbersome for routine use and is better suited for the calibration of other instruments (see Sections 3.1.4 and 3.3).
In principle, any of several neutron detectors can be employed to determine the absorbed dose of neutrons, including ionization instruments, solid-state devices, activation and fission methods, and ferrous sulfate dosimeters. (See Section 3.3 for detailed discussions of these methods.) In practice, however, clinical neutron dosimetry relies on and is based on measurements made with nearly homogeneous TE ionization chambers, because these instruments provide both accuracy and convenience in comparison with other methods. These TE dosimeters are used either free in air to characterize the neutron beam, or inserted into phantoms made of tissue-simulating materials to determine the absorbed doses in patients.
The status of ionization chambers and their use for neutron dosimetry has been reviewed (CEC, 1980) . Because the characteristics of the separate types of chambers may differ, it is recommended that a common type of TE ionization chamber be used as a reference instrument.
Reference Phantom Material
Tissue-equivalent phantoms are used to obtain basic depth-dose data and for the generation of isodose contours. The choice of material for a reference phantom is dictated by the same principles as for ionization chamber materials, i.e., it should be matched to muscle tissue so as to have the same or very similar neutron absorption and scattering properties. According to ICRP Report 23 (ICRP, 1975) , muscle, as well as other tissues such as liver and kidney, has densities varying between 1.03 and 1.05 g cm-3 . An ideal phantom material therefore, would be a muscle tissue-equivalent liquid with a density of 1.04 g cm-3. The fat-free, muscle-equivalent liquid of Frigerio et al. (1972) has been used as a standard TE liquid medium for reference phantoms. This liquid mixture is exactly equiva-21 lent to ICRU muscle tissue in the major elemental ingredients, C, H, N, and 0, and it also contains the correct amounts of the trace elements in muscle tissue. Its density, however, is 1.07 g cm-3 which compares well with that of adipose-free muscle but is higher than that of muscle. In the majority of applications, it is not necessary to reproduce in a phantom the trace elements present in tissue. It will suffice in most cases to simulate tissue by the simpler three component mixture of Goodman (1969) . This mixture also has a density of 1.07 g cm-3 and is much easier to prepare.
As in the case of photon beams, water can also be used as the reference phantom material for purposes of clinical tissue-absorbed dose determination. It :has been shown that central axis percentage depth-dose curves in water almost coincide with those in a muscleequivalent liquid of density 1.04 g cm-3 (Catterall and Bewley, 1979; Awschalom et al., 1983c; Vynckier et al., 1984) . Water has been found to be valid as a suitable medium for the low-as well as the high-energy therapeutic neutron beams. The lower density of water compared with the average density of muscle is apparently compensated by the difference in composition, i.e., the higher hydrogen content of water. The difference in absorbed-dose values measured in water and in TE liquid of density 1.07 g cm-3 is acceptable for clinical practice at low-neutron energies, i.e., it is smaller than one percent at depths between 2 and 12 cm for d + T and d(15) + Be neutrons. For higher neutron energies, differences of several percent can occur (Mijnheer et al., 1981a) . It should be noted that to obtain absorbed-dose distributions in irradiated patients, correction factors are needed for all phantom materials to correct for differences in atomic composition and density between the phantom and the irradiated volume in the patient (see Section 5.1). Based on these conclusions, it is recommended that water should be used as the reference phantom material.
Most dosimetry protocols recommend that the phantom container be an open-top cube with 30-cm sides and be made of about 6-mm thick material such as polymethylmethacrylate (PMMA, Lucite, Perspex) . This size is deep enough to provide maximqm backscatter and large enough to provide about a 5-cm margin about the largest practical irradiation field size. The wall thickness of the container is chosen to prevent excessive flexing of the sides but a thinner beam-entrance window (.-3 mm) is recommended to permit ionization chamber measurements to be made at shallow depths without significant perturbation by the plastic wall (see Section 4).
The absorbed dose at the reference point in the reference phantom should be related to the monitbr reading. For check measurements, however, it may be more convenient to use a simple test situation, with the purpose of assessment of the constancy of the monitor. Ford+ T neutron generators and low-energy cyclotrons, a measurement in free air will suffice. For higher neutron energies, a measurement with an ionization chamber at a fixed depth in a solid phantom of convenient size and material, e.g., polyethylene, polystyrene or acrylic plastic, under specified conditions, is recommended (see Section 4.1). The requirement for a small cavity or a homogeneous chamber need not be satisfied for a monitoring instrument or when the chamber is calibrated against a dosimeter in a radiation field qualitatively similar to that of its intended use. For example, an air-filled chamber with TE plastic walls is sometimes used to check the absorbed dose in a neutron field by making use of a predetermined response ratio of such a chamber in comparison with its response with a TE gas filling in the same or a similar radiation field. Monitoring is discussed more fully in ICRU Report 26 (ICRU, 1977) .
Other phantom materials have been used for specific applications (see Section 3.1.5).
Reference Dosimeter Material
The Bragg-Gray principle is based on the assumption that the charged particles produced by neutrons in the wall material of an ionization chamber lose a negligible fraction of their energy in traversing the gas cavity. This requires use of a small cavity. Alternatively, a homogeneous chamber, i.e., a chamber with walls and gas of the same composition can be used. Homogeneous chambers are used almost exclusively in clinical neutron dosimetry for two reasons: first, because the requirement for small cavities is difficult to achieve for chambers yielding adequate ionization current for reliable measurement; and second, because cavitychamber data applicable to neutron dosimetry with nonhomogeneous chambers are sparse. Chamber homogeneity is achieved for neutron dosimetry by using wall, gas, and insulator materials that have the same energy transfer coefficient for the primary radiation and the same stopping power for the secondary particles. Since the principal concern of this Report is the measurement of neutron absorbed dose in tissue, the ideal material for a homogeneous chamber is one that is tissue-equivalent. "Tissue-equivalent" here means an atomic composition similar to that of tissue. Such materials may be called tissue substitutes (ICRU, 1989) . Care must be exercised to specify the tissue composition being matched and the neutron energy range in which this match is maintained with acceptable accuracy. In practice, neither exact matching to tissue nor exact matching for homogeneity is usually achieved. Thus, it is generally necessary to compro-mise these ideals and apply small to moderate corrections (about 5% or less) to measured values.
The wall material commonly used and recommended for clinical neutron dosimetry is a tissue-equivalent plastic designated A-150, 3 and the cavity gas is a methane-based TE gas mixture. The gas contains 64.4 percent methane, 32.4 percent carbon dioxide, and 3.2 percent nitrogen by partial pressures. Hydrogenous insulator materials suitable for use in ionization chambers are amber, nylon, polyethylene, polymethylmethacrylate, and polystyrene. If insulators have substantial volume compared to the gas volume, then care must be exercised to use an insulator with a composition similar ,to A-150 plastic. Further information on A-150 plastic, the gas, and other tissue-like materials is given in the appendices of ICRU Report 26 (ICRU, 1977) . Goodman (1985) has discussed the future of A-150 plastic in view of the composition .change that will be required due to the unavailability of the nylon component in the plastic mixture. His discussion of possible changes in TE plastic composition concludes that no significant improvements appear to be possible except to reduce the nitrogen content from its value of 3.5% by mass in A-150 plastic to 2.6% in a new TE plastic. Analyses of the elemental composition of A-150 plastic have been reported by Smathers et al. (1977) and by Goodman (1978) . The elemental compositions of A-150 plastic and methane-based TE gas are compared to that of muscle tissue (ICRU, 1964) and soft tissue (ICRU, 1980) in Table 3 .1.
The nitrogen content in ICRU soft tissue is in better agreement with the average nitrogen content in most tissues and organs than is that in ICRU muscle tissue (Goodman, 1985) . However, the hydrogen content of ICRU muscle tissue differs from that in ICRU soft tissue (see Table 3 .1), requiring a 1% different kerma correction factor in high-energy neutron beams for muscle tissue compared to soft tissue (see Table 5 .2). Because a vast amount of clinical information is already based on it, it is recommended that ICRU muscle be taken as the reference tissue. The principal compromise made in the formulation of A-150 is the substitution of carbon for much of the oxygen required to match muscle tissue. The methane-based TE gas mixture used with this plastic is also deficient in oxygen, but to a lesser extent. This deficiency, and the concomitant excess of carbon, generally results in an increase of several percent in the energy released by neutron interactions in the plastic, relative to that released in muscle tissue. Additional fluctuations of several percent at various neutron energies also result from significant disparate resonances in the interaction cross sections of oxygen and carbon (Caswell et al., 1980) . The use of A-150 plastic-equivalent gas has been suggested by Bewley (1980) , Awschalom and Attix (1980), and Awschalom et al. (1982b) because the match of the methane-based TE gas to the A-150 plastic wall is poor with respect to carbon and oxygen. The use of this gas is, however, not recommended because it has several disadvantages over the methane-based TE gas, e.g., less accurately known W values.
Determination of Total Absorbed Dose from TE Ionization Chamber Measurements
The measurement of absorbed dose by means of an ionization chamber is based on the Bragg-Gray relation:
where Dis the absorbed dose in the wall surrounding a cavity, Q is the charge of one sign produced within the cavity, mis the mass of the cavity gas, Wis the average energy expended per ion pair formed in the gas, e is the electronic charge, and Sm,g is the mass stopping-power ratio for the wall material, m, and the gas, g, of the chamber for the charged particles liberated in the wall. It is assumed that the dimensions of the cavity are small compared with the range of the charged particles that impart the absorbed dose and that the cavity does not disturb either the neutron and photon fluence, or the secondary particle fluence. The application of the Bragg-Gray relation to neutron dosimetry with tissue-equivalent ionization chambers is subject to a number of corrections as well as spectral averaging of physical quantities. In the practical situation, Eq. 3.1 can, therefore, be given in the form:
where Wn is the W value to be applied for a neutron beam and is an average value for a mixture of secondaries. Wn has to be evaluated for all secondary parti- cles, having different mass and energy, originating from neutron interactions with the wall or the cavity gas, producing charge in the cavity. (rm,g)n is the gas-to-wall absorbed-dose conversion factor. If the atomic composition of wall and gas are the same, and assuming that the density correction to stopping power can be neglected, Sm,g will be unity. Because the atomic composition of wall and gas are generally not the same (see Section 3.1.1), sm,g has to be evaluated for the different secondary particles. In most neutron beams, not only secondary particles generated in the wall produce ionizations, but the gas cavity also contributes significantly to the secondary particle spectrum. sm,g• which applies when the ionization chamber can be considered to have a Bragg-Gray cavity, is, therefore, in neutron dosimetry replaced by (rm,g)n.
dT is the displacement correction factor. This factor accounts for the difference in absorption and scattering when the ionization chamber is in the phantom and when the chamber is replaced by phantom material. Due to the finite size of the cavity and the other parts of the ionization chamber, the neutron energy fluence is perturbed and the charge collected has to be multiplied by dT. Such a procedure yields the total absorbed dose at the geometric center of the chamber.
o is a correction that has to be introduced to correct for the difference in response of the TE chamber for neutrons and photons in the neutron beam. Its definition and numerical values will be discussed in Section 3.1.4.
The total absorbed dose, Dn + D-y, the sum of the neutron and photon absorbed doses to ICRU muscle tissue, can now be given by:
where (KJKm)n is the ratio of the kerma in the reference tissue (ICRU muscle tissue) to that in the dosimeter wall material (A-150 plastic).
The total absorbed dose may then be evaluated from the charge produced in the TE chamber in a neutron beam:
Several methods are available to calibrate TE ionization chambers, i.e., to determine the mass of the gas in the chamber and the absolute value of the energy expended within the cavity. Until now it has been recommended that the chamber be calibrated in a photon field relative to a secondary standard exposure chamber which has a calibration factor traceable to a national standards laboratory. However, one ~t calibrate a TE ionization chamber in a neutron be the kerma or absorbed dose, under the calibration conditions, is well-known. Standards laboratories are presently developing methods for providing calibration in terms of such quantities. If the TE ionization chamber is calibrated in a reference neutron field with well-known absorbed-dose components, then the overall uncertainty in a total absorbed-dose measurement in an unknown neutron field will be smaller than when a photon calibration is applied (Mijnheer and Williams, 1984) . This is mainly because only the relative energy dependence of W n values and (r m,g)n values are needed and not the absolute values. Using an A-150 plastic calorimeter, Caumes and Simoen (1984) were able to provide a primary standard of absorbed dose yielding the smallest uncertainty in the A-150 plastic absorbed-dose calibration factor. An additional advantage of a calibration in a neutron beam compared to a photon calibration is that any uncertainty in elemental composition of the wall material will have a smaller effect on the absorbed-dose determination in the unknown field. The differences of several percent in responses in neutron beams, observed with individual chambers of the same design having an exposure calibration (Mijnheer et al., 1981a) , will be reduced. It is, therefore, recommended that in the future ionization chamber calibration should also be performed in a neutron beam, either in a reference neutron field or directly in the user's beam. An exposure or air-kerma calibration in a photon beam is, however, a more practical calibration method at this moment for most radiotherapy institutes. Air-kerma determinations have a smaller uncertainty than exposure determinations. For this reason, air-kerma calibration will be the method preferred by most standards laboratories (BIPM, 1981) and it is also the procedure recommended in this Report.
Photon Calibration of TE Ionization Chambers
The calibration of TE ionization chambers in absolute terms has been discussed in Section 3.1.3. In this Section, equations will be derived for the determination of total absorbed dose from the reading, MT, of a TE ionization chamber when used in a phantom, irradiated by a neutron beam, applying a photon calibration factor. Both during the photon calibration and the measurement in the phantom it is assumed that the wall of the chamber and its build-up cap are sufficiently thick to produce charged-particle equilibrium. In this way, charged particles crossing the cavity will have been liberated either in the wall, the build-up cap, or the cavity gas and not in the phantom material.
Currently, in neutron dosimetry, the mass of gas, m, is most commonly derived from an exposure calibration of the chamber. An exposure calibration factor, Nx, is defined as:
x Nx= -· QC (3.5) where Xis the exposure free-in-air at the center of the ionization chamber in the absence of the chamber, with subscript c referring to the calibration quality (usually 6°C o gamma rays or 2 MV x rays). The relation between m and Nx can be derived (e.g., see Mijnheer and Williams, 1981) , yielding:
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(3.6) where Awa11 is a factor that corrects the chamber response for the absorption and scattering in the chamber wall, its build-up cap and stem when measurements are made in air in the calibration beam. Values for Awall have been calculated for a number of commercially available ionization chambers exposed to 6°C o gamma rays (Nath and Schulz, 1981; Rogers et al., 1985) . A value of Awa11 = 0.983 for a wall and build-up cap thickness of 590 mg•cm-2 can be derived from their data, although small deviations may occur due to differences in chamber design.
Under conditions of electronic equilibrium, <ft)e is the exposure-to-absorbed dose in reference tissue conversion factor. This conversion factor is defined as:
( 3.7) where ( W air)e is the average energy expended per ion pair formed in dry air by the photon calibration source, µenf p is the mass energy absorption coefficient and the subscript t refers to tissue. The most recent evaluated value of (Wair/e)e is 33.97 ± 0.06 J c-1 (Boutillon and Perroche, 1985) . This value for dry air replaces the value of 33.85 J c-1 recommended in ICRU Report 31 (ICRU, 1979) . The most recent value for (µen! p)J(l'enf p)a1r for photon energies around 1 Me Vis 1.102 (Hubbell, 1982) . This yields a value for <ft)c of 37.4 J c-1, corresponding to 9.66 X 10-3 Gy R-1 .
We is the average energy expended per ion pair formed in the gas of the ionization chamber by the photon calibration source. The value We = 29.3 e V is recommended for the methane-based TE gas (Goodman and Coyne, 1980) . (LI p)e is the mean restricted collision mass stopping power for the slowing down spectrum of electrons released by the calibration radiation (see for instance AAPM, 1983) . No single values for (L/p)c are recommended, but values for the ratio (rm,g)n/[(L/p)m/(L/ p)g]c will be discussed in the next Section.
Substitution of m into Eq. 3.4 yields the general expression for the calculation of the total absorbed dose, DT, from the reading of a TE ionization chamber when used in a phantom irradiated by a neutron beam:
where MT is the electrometer reading of the TE chamber in the neutron beam and (IlkMh is the product of several factors used to correct the electrometer reading to the charge Q 0 produced in the cavity at standard temperature and pressure conditions. lfkT is defined as:
The final correction factor 1/(1 + 0), which corrects for the difference in response of the TE chamber for neutrons and photons in the neutron beam, has to be added to MT. o is given by: (3.10) in which hT is defined similarly to kT for the photon component of the neutron beam. It is usual to assume hT = 1 and, generally, kT ranges from 0.95 to 1.00. For the fast neutron beams used in radiotherapy, usually D-y is less than 20 percent of the total absorbed dose, Dn + D-y. Thus o is generally less than 0.01.
Eq. 3.8 can be rewritten as:
which is the equation given in ICRU Report 26 (ICRU, 1977) , where
D'T is the quotient of the reading of the dosimeter, used in the phantom irradiated by a neutron beam, corrected for temperature and pressure, recombination and polarity, and displacement, and its response to the calibration radiation. D'T is related to the total absorbed dose by the dimensionless factors kT and 1 + o. It should be noted that if the displacement correction factor is not applied, then Dn and D-r are obtained at the effective point of measurement, which will be displaced from the geometric center of the chamber.
Eq. 3.8 may also be rewritten to give:
where
Cn is then analogous to Cx which is used in photon dosimetry and, for instance, is discussed in ICRU Report 24 (ICRU, 1976) . Cx relates the chamber reading in a photon beam of energy X to absorbed dose to water 3. 1 Measurement of Absorbed Dose ••• 25 in a phantom using the exposure calibration factor. C 0 would depend on the neutron energy and, like Cx, on the geometry of the chamber and the materials of which it and its build-up cap are constructed. In addition, there will be a small dependence on the rela~ive gamma-ray component of the neutron beam. By ig oring these dependencies, approximate values for C as for Cx can be tabulated as a function of neutron energy, but a higher accuracy can be obtained by applying the extended formula using the individual quantities contained in Cn.
An exposure calibration factor, Nx, can be convertd into an air-kerma calibration factor, NK, by Jlymg: ) where g is the fraction of energy of secondary charged particles that is converted to Bremsstrahlung in air.
The most recent calculation of this fraction for electrons produced by SOCo gamma rays in the graphite wall of an ionization chamber amounts to 0.003 (Boutillon, 1985) . Substituting NK into Eq. 3.8 yields the equation for the determination of total absorbed dose from an ionization chamber measurement in a phlmtom irradiated by a neutron beam, applying an l!rlrkerma calibration factor:
Because it is likely that air-kerma calibration will be the method preferred by most standards laboratories in the future, it is recommended that this procedure and the resulting Eq. 3.16 be used if an air-kerma calibration factor is available. A different method of calibrating a TE ionization chamber may be used when a standard is available which gives the absorbed dose to water under specified conditions in a water phantom irradiated with photons. This method of calibration has been studied by Williams and Greening (1980) . Such a standard gives the absorbed dose to water, (Dw)c, at the position of the geometric center of the chamber, the chamber being replaced by water. By comparison with the standard, the calibration factor, Nw, of the TE ionization chamber can now be determined from the equation In neutron dosimetry, however, the quantity required is absorbed dose to tissue. The absorbed dose to water measured by the standard dosimeter must, therefore, be corrected to the absorbed dose to tissue using the ratio of the mass energy absorption coefficient in tissue to that in water. Nw includes the 1is,. placement correction factor, de, valid for the phorn calibration conditions in a water phantom. For the irradiation of a phantom in the neutron beam, a different displacement correction factor, dT, is necessary. Consequently, the measured reading, MT, has to be multiplied by dT/dc. Equation 3.8 can now be rewritten applying N w. yielding:
Physical Parameters Employed to Calculate Total Absorbed Dose from TE Ionization Chamber Measurements
The overall uncertainty in the assessment of absorbed dose from TE ionization chamber measurements in a neutron field is much larger than that from measurements in photon and electron beams (see Table 3 .2). Because of continuing efforts to improve the data base of neutron dosimetry, recommended values for the physical parameters applied in Eq. 3.16 and given in this Report, differ from those given in ICRU Report 26 (ICRU, 1977) and from those given in the protocols cited previously. They may be also subject to future changes. It is anticipated that the adoption of a common set of basic physical parameters will achieve greater consistency in clinical neutron dosimetry. The parameters discussed in this Section will be (r m,g)n, • A lower value of 3.4% is valid for a d(l6) + Be beam having all sources of uncertainty the same except the uncertainty in the ratio of neutron kerma, which is about 1.5%.
Wm (KJKm)n. and dT, whereas the parameters required for the photon calibration procedure have been discussed in Section 3.1.4. Gas-to-Wall Absorbed Dose Conversion Factor. Only limited information is available for the gas-towall absorbed dose conversion factor for neutrons, (rm,g)m which was formerly called the effective stopping-power ratio. ICRU Report 26 (ICRU, 1977) assumed (r m,g)n = 1 to be a valid approximation for most neutron energy spectra. Its calculation is complicated due to the differences in number and spectra of secondary particles. The absorbed dose conversion factors used in the past by the United States neutron therapy groups are given in Smith et al. (1975) and the factors previously used by the European groups are listed in Broerse et al. (1978) . Bichsel and Rubach (1978) calculated neutron absorbed dose conversion factors for a TE ionization chamber consisting of a Bragg-Gray cavity and for chambers of finite volume. More recently, these authors presented extensive calculations of (r m,g)n at specific neutron energies and for some cavity sizes (Rubach and Bichsel, 1982a ). If the values at "point energies" near extreme values in total neutron cross section are excluded, their values for a 1-cm3 chamber vary between (rm,g)n = 0.981 and (rm,g)n = 1.001 for neutron energies between 5 and 14 MeV. A survey by Dennis (1980) suggests that for most neutron energies, (r m,g)n would lie in the range of 0.95 to 0.99 and is most likely to be toward the higher end of this range. The uncertainty in this ratio given by Dennis is 1 to 2 percent. This deviation from unity is caused by the phase effect, a higher stopping power for the gas compared to a solid material of identical atomic composition. Pszona and Makarewicz (1982) and Burger and Makarewicz (1987) gave results of calculations of (rm,g)n for A-150/TE gas ionization chambers. They obtained values varying between about 0.98 and 1.06, depending on the neutron energy and electrode distance. Th~ deviation from unity is caused by the difference in both stopping power and atomic composition between A-150 plastic and TE gas. Because the accuracy of calculations of (rm,g)n and [(L/p)m/(L/p)g]c is limited due to the lack of adequate stopping-power data for the gas and solid phases and due to the neutron energy dependence of (rm,g)m a value of (rm,g)n/ [(L/p)m/(L/p)g]c = 1.00 ± 0.02 is recommended for the TE ionization chambers and neutron energies employed for neutron therapy.
Energy Required to Produce an Ion Pair. Values of Wn and of Wn!Wc in the methane-based TE gas can be found in Goodman and Coyne (1980) for neutrons with energies up to 20 MeV. This reference states that Wn is almost constant at 31.1 eV for neutron spectra with mean energies greater than 5 Me V and that this is probably true for neutron energies somewhat higher than 20 MeV. In principle, the Wn values calculated by these authors are only valid for chambers having diameters that are very large compared with the range of the recoil particles because TE gas kerma, instead of absorbed dose to TE gas, was used in their calculations. Rubach and Bichsel (1982a) , Siebert and Coyne (1984) , and Burger and Makarewicz (1987) showed, however, that for a cavity of finite size, the size dependence of the calculated W n value is less than 0.6 percent for neutron energies between 1and20 MeV. The differences in Wn between the results of the calculations of these groups and those of Goodman and Coyne (1980) are less than 1 percent. For the methane-base TE gas and the neutron spectra typically employed for therapy applications, a value Wn!Wc = 1.06 ± 0.02, for which the value We= 29.3 eV was used, was recommended by Goodman and Coyne (1980) . The American protocol (AAPM, 1980) cites current practice in the United States but makes no recommendation as to the value to be adopted. The European protocol (Broerse et al., 1981) recommends that Wn!Wc = 1.06 be used for most neutron radiotherapy beams. A value of Wn!Wc = 1.05 was recommended in ICRU Report 26 (ICRU, 1977) with an uncertainty of ±5 percent for neutron energies above 1 Me V and an increased systematic uncertainty at lower energies. It is recommended that the kerma weighted Wn!Wc should be calculated from the consistent set of data of Goodman and Coyne (1980) for neutron beams with energies up to about 15 MeV, if the neutron energy spectrum at the reference point is available. For the relative kerma spectra presented in Figure 2 .2, W n!Wc values varying between 1.063 at the surface and 1.068 at 10-cm depth outside the penumbra can be calculated. This indicates that position-independent Wn!Wc values can be applied for the determination of isodose curves. For neutron energies higher than about 15 MeV, or, if no spectral data are available, a value of W nf Wc = 1.06 ± 0.02 should be adopted.
Neutron Kerma Ratio. The ratio of the kerma in the tissue of interest to the kerma in the dosimeter wall material (A-150 plastic), (KJKm)n, is needed to convert the absorbed dose measured by the dosimeter to that which would be produced in tissue, and may be calculated for a given neutron spectrum by Eq. 5.1. Since the tissue type in the clinical situation is often not welldefined, it has become customary to assume that the composition of ICRU muscle tissue (Table 3 .1) is sufficiently representative of the actual tissue(s) to be irradiated with fast neutrons. The neutron kerma ratios for ICRU muscle tissue relative to A-150 plastic which have been used in the past by the United States neutron therapy groups are given by Smith et al. (1975) and range from 0.95 to 0.96. Appendix A of ICRU Report 26 (ICRU, 1977) gives the kerma factors for these materials for neutron energies up to 30 MeV. This tabulation has been updated by Caswell et al. (1980, 1982) . The 3. 1 Measurement of Absorbed Dose ••• 27 new data show some changes when compared with the older data, especially for neutron energies in excess of 7 Me V. The kerma factor for ICRU muscle changed, for instance, by 1.4% at 14.5 MeV. The main reasons for the differences are the availability of better data on the total cross section for carbon and a different treatment of the 12 C(n,n')3a reaction.
For neutron energies greater than 30 Me V and u:p to 80 Me V, kerma factors have been calculated by Alsmiller and Barish (1976) , Wells (1979 ), Dimbylow (1980 , Behrooz and Watt (1981) , Herling et al. (1981), and Dimbylow (1982) .
Bewley (1980), using existing kerma factor data for hydrogen, carbon, nitrogen, and oxygen, has calculated kerma factors and their uncertainties for several materials and tissues relative to those for ICRU muscle tissue for three neutron therapy spectra. He calculated values for the uncertainty in this kerma ratio varying between 1.3 percent for d(l6) + Be neutrons and 4.8 percent for p(66) + Be neutrons. A subsequent report by Awschalom et al. (1983b) provides kerma factors and their uncertainties for various substances averaged over the energy spectra of fast neutron therapy beams, as well as ratios of average kerma relative to ICRU muscle (Table 5 .2). These calculations are used to estimate the uncertainties introduced into these quantities by the poor knowledge of the kerma factors for individual elements, actual neutron energy spectra and composition of tissues and other materials. The average kerma factors derived have uncertainties of the order of 10 to 20 percent, while for ratios of average kermas the uncertainties are of the order of 2 to 4 percent for materials of clinical interest.
Since kerma factors depend on the neutron spectrum, an attempt should be made to obtain information on the radiation spectrum at the point of interest. It is recommended that the neutron kerma ratio be calculated for the neutron energy spectrum at the reference point on the basis of the updated set of kerma values of Caswell et al. (1980, 1982) for neutron energies up to about 15 MeV. The uncertainties in the kerma factors for tissue and for tissue-like materi, als increase with energy from about one percent at lowneutron energies, to 10 or more percent at the higher energies employed for neutron therapy. However, kerma ratios are much less dependent on neutron energy. Until more reliable data on spectra and kertna factors for neutron energies greater than about 15 Me V become available, it is recommended that the ratio of kerma in ICRU muscle to A-150 plastic be taken as 0.95 for the high energy beams.
Displacement Correction. The displacement correction accounts for the reduced absorption and SCflttering of the radiation sensed by an ionization chamber due to the displacement of phantom material by the gas cavity of the chamber. This correction can take the form of a multiplicative factor, dT, which adjusts the measured ionization to the value that would be obtained if the cavity were filled with phantom material, or it can be expressed by stating the position of the effective measuring point as a certain fraction of the radius of the gas cavity upstream of the chamber's geometrical center (Hettinger et al., 1967; Dutreix and Dutreix, 1966) . The American protocol (AAPM, 1980) uses the multiplicative-factor method and recommends for all clinical neutron beams a factor of 0.970 for the l-cm 3 spherical chamber and 0.989 for the O.l-cm3 thimble type chamber, based on the measurements of Shapiro et al. (1976) . These factors can be applied only to the descending portion of the depthdose curve, i.e., where the curve is approximately exponential, and the measurements show that the factors are not dependent on neutron beam field size. The European protocol (Broerse et al., 1981) also recommends use of multiplicative displacement correction factors. Their recommendations are based on the measurements of Zoetelief et al. (1980a, b) for spherical TE ionization chambers in a water phantom. These measurements showed no change in the factors with depth in the phantom.
For a l-cm 3 spherical ionization chamber, the data of Zoetelief et al. (1980a, b) would result in a factor dT = 0.984 ± 0.004 for d(50) + Be neutrons. For a chamber of the same dimension Awschalom et al. (1983a) derived a value of 0.970 ± 0.005 for p(66) + Be neutrons, which agreed very well with the value obtained in a d(35) + Be neutron beam by Shapiro et al. (1976) but is lower than the value given by Zoetelief et al. (1980a, b) . For a 0.5-cm3 thimble type of ionization chamber the results of Awschalom et al. (1983a) are equal to, or within the experimental uncertainties of other methods (Hensley and Rassow, 1981; Williams et al., 1982) .
Because all of these groups used different techniques to determine dT, each having its own uncertainty, recommended values for the displacement factors for neutron therapy beams are taken as the unweighted averages of all results yielding 0.978 ± 0.004 for a l.O-cm3 spherical chamber; 0.986 ± 0.003 for a 0.5-cm 3 thimble chamber; and 0.993 ± 0.002 for a 0.1-cm 3 thimble chamber. The systematic uncertainty in dT due to the somewhat different data can be minimized by using small ionization chambers.
Overall Uncertainty. The overall uncertainty in the determination of total absorbed dose, Dn + D'Y, in a phantom irradiated by a neutron beam using a TE ionization chamber and applying Eq. 3.16 is given in Table 3 .2.
The indicated uncertainties are one standard deviation and are either estimated or taken from the references mentioned above and may, therefore, differ somewhat in their definition. It can be seen from the table that at higher neutron energies, the overall uncertainty is mainly determined by the uncertainty in the kerma factor ratio. If a chamber wall material matching a reference tissue more closely were available, the uncertainty in the kerma factor ratio would be reduced. The uncertainty is smaller if the chamber is calibrated in a standard neutron field: 3.6% and 1.8% for p(65) +Be and d(16) +Be beams, respectively. An uncertainty of 0.85%, one standard deviation, in the A-150 plastic absorbed dose calibration factor was taken (Caumes and Simoen, 1984) . (See Sections 3.1.2 and 3.3.1.)
Other Phantom Materials
For some applications, e.g., checking calculated dose distributions in anthropomorphic phantoms, it is more practical to use phantom materials other than water. For a particular neutron energy, absorbed-dose distributions in different phantom materials will vary with atomic composition and density of the phantom material. These differences in total absorbed dose at a specific depth can be considered as a combination of differences in total absorbed dose at the dose maximum (peak absorbed dose) and of differences in percentage depth-dose data.
Only limited information is available on peak absorbed dose in different materials. Peak absorbed dose in polystyrene and in the TE liquid of Frigerio et al. (1972) , relative to water for the same field size, showed differences of up to about 4% (Vynckier et al., 1985a) . Differences less than 3% were observed when the neutron beam quality varied between d(l4) + Be and p(65) +Be. These differences might be attributed to differences in backscattered radiation in the different phantom materials. Percentage depth-dose distributions are systematically altered with variation of the atomic composition and density of the phantom material for the same neutron beam quality. Measurements at different neutron beam qualities in several commonly used liquid and solid phantom materials, have shown that, to a good approximation, this effect can be corrected for by scaling the abscissa (phantom depth) of the percentage depth-dose distributions.
The scaling factor, SF(z), of material a to water can be derived from percentage depth-dose measurements in both media using the formula:
with PH 2 o(z) and P 8 (z), the percentage depth dose at depth z, extrapolated to infinite SSD for water and for material a, respectively, and µH 2 o(z) an effective linear •TE-liquid with composition according to Goodman (1969) . b TE-liquid with composition according to Frigerio et al. (1972) . c TE-liquid with composition according to Rossi and Failla (1956) . d 2-cm polyethylene hardening mter. attenuation coefficient for water at depth z (Vynckier et al., 1985b) . These empirical scaling factors, Table  3 .3, are for the materials presented in that table within the experimental uncertainty independent of the field size of the neutron beam and of depth in the phantom. Differences in SF attributable to changes of the initial neutron energy spectrum and fluence of the gamma rays are obviously negligibly small (Hensley et al., 1985) .
For photon beams, equal attenuation of the incident beam is approximately obtained when the depth in two phantom materials is related by a scaling factor which is equal to the ratio of the mean linear attenua-3. 1 Measurement of Absorbed Dose ••• 29 tion coefficients for the incident photon spectrum in the two media (e.g., see AAPM, 1983) . A similar scaling factor is valid for neutron beams (Awschalom et al., 1983c) . These authors calculated scaling factors based on the kerma-weighted mean free path, i.e., the reciprocal of the linear attenuation coefficient. Tre applicability of this scaling factor was verified in soi:ne materials for the Fermilab p(66) +Be beam by good agreement with the experimental results. Differences of about 10% were observed, however, between calculated scaling factors and experimental data for other materials in the Louvain p(65) + Be beam. Most of these differences decrease with decreasing neutron energy although for the d(l4) + Be beam, differences of up to 8% have been observed for some materials (Hensley et al., 1985; Vynckier et al., 1985b) .
Scaling (1985b) . SF/p 8 will, in general, be higher for materials consisting mainly of carbon and hydrogen rather than of oxygen and the same amount of hydrogen. The hydrogen influence on the attenuation decreases with increasing neutron energy due to the decreasing total cross section of hydrogen relative to that of carbon or oxygen. Because, at these higher neutron energies, uncertainties in the total cross section are important, it is difficult to make an accurate calculation of the scaling factors for high-energy neutron beams. At neutron energies below about 10 MeV, strong resonances occur in the total cross section of carbon, oxygen, and other elements, thus making accurate calculations of the scaling factor complicated. It is recommended, therefore, that the experimental scaling factors given in Table 3 .3 be used for converting percentage depthdose distributions in a particular medium to those in water.
The composition of the phantom materials can be found elsewhere (e.g., ICRU, 1977 and Vynckier et al., 1985b) . Some of these phantom materials, e.g., white polystyrene, might have varying composition due to the addition of unknown amounts of Ti02 (White, 1978) . In view of the relatively large and uncertain corrections, the employment of some of the substitute phantom materials should be avoided.
Measurement of Gamma-Ray Absorbed
Dose in a Neutron Field An evaluation of the separate neutron and gammaray absorbed-dose components in a mixed field can be made with a single instrument. In a TE proportional counter, the energy deposition events due to electrons can be separated from those resulting from protons, alpha particles, and heavy recoils with higher LET values (see, e.g., Bichsel, 1975; Menzel and Schuhmacher, 1980; and ICRU, 1983) . After fitting a pure gamma-ray spectrum to the mixed field spectrum, the gamma-ray absorbed-dose fraction can be derived from the areas under both curves as indicated in Figure 3.1 . Electron pulses and heavy ion pulses are better separated in pulse-height spectra measured with proportional counters having a graphite wall and using various nonhydrogenous gases as counting gas (Caswell, 1960; August et al., 1978; DeLuca et al., 1981; and Buhler et al., 1985) . The improved separation is due to the absence of the events from elastically scattered recoil protons. The disadvantage of the use of proportional counters in neutron therapy beams is the high sensitivity, the method is complicated and there is the necessity to analyze signals with pulse height having a dynamic range of about five decades (e.g., see Stinchcomb et al., 1980) . The ratio of photon to neutron absorbed dose, D.rf Dn. can be determined with a TE proportional counter with an overall uncertainty of about ±10 percent, provided that systematic and random uncertainties are kept to a minimum. The proportional counter technique can thus be used as a reference method to measure the contribution of photons to the total absorbed dose, but it is not suitable for routine measurements.
Using a TE ionization chamber, the components of the current induced by neutrons and photons can be separated by the method of variance measurement (stochastic current analysis) developed by Bengtsson and Lindborg (1974) and applied by Sherwin (1975) for neutron beams. The method has proved to be sue-0.4 I --;;: 0.3 "O cessful in the measurement of the radiation components arising from a 252 Cf neutron source. An uncertainty of about 4 percent was indicated for the ratio of the neutron and photon absorbed doses around a 252 Cf source. Also, for a d(15) + Be neutron beam, the values of the gamma-ray component have been measured by the stochastic current method and were not significantly different from those derived from the two-dosimeter method (Williams, 1981) . However, these results were not conclusive due to experimental uncertainties. The variance method should be tested at other neutron energies.
Assessment of the photon component of absorbed dose in a mixed field is generally made by the twodosimeter method, using a dosimeter which is relatively insensitive to neutrons in conjunction with a TE ionization chamber. Nonhydrogenous ionization chambers such as graphite-walled chambers filled with C0 2 and Mg-or Al-walled chambers filled with argon can be used for this purpose. Other dosimeters with a low neutron sensitivity are some types of thermoluminescent materials, photographic emulsions, and Geiger-Muller (GM) counters. The properties of these devices have been discussed extensively in ICRU Report 26 (ICRU, 1977) . New results on the neutron response of ionization chambers and GM counters will be discussed in this Report because these devices are often employed in clinical neutron dosimetry.
According to ICRU Report 26 (ICRU, 1977) , the quotient of the reading of the dosimeter by its response (i.e., the reading per unit absorbed dose) to the gamma rays used for calibration, D'u, is given by: where ku and hu are the ratios of the responses of the dosimeter with a low neutron sensitivity to the neutrons and photons in the mixed field, respectively, to its response to the gamma rays used for calibration. This equation is similar to Eq. 3.11 given for the TE ionization chamber:
(3.11)
Solving the simultaneous Eqs. 3.11and3.20 yields the separate absorbed-dose components Dn and D-r. The accuracy with which neutron absorbed dose can be determined is, in general, greatest when a dosimeter with the smallest possible ku is used (ICRU, 1977) . Methods for deriving ku values are the lead filtration technique, the spectral difference method [both described in ICRU Report 26 (ICRU, 1977) ], the associated-particle coincidence technique (Lewis and Young, 1977) and the time-of-flight technique (Klein et al., 1979) . These four techniques have been compared, using the same Geiger-Muller counter, at neutron energies of approximately 0.6, 5, and 15 Me V (Mijnheer et al., 1982) . Excellent agreement was obtained at 15 MeV (maximum difference 1.5%) and agreement within the estimated uncertainties, which varied between 12 and 25%, at 5.5 MeV. At 0.6 MeV, only the time-of-flight method gave an accurate result. ku can also be determined if the dosimeter is placed in a neutron field where the ratio of the photon absorbed dose to the neutron absorbed dose is known, e.g., by means of the TE proportional counter method (Ito, 1978b) .
Nonhydrogenous ionization chambers with several wall and gas combinations are employed, in particular C-C02, Mg-Ar, and Al-Ar. The C-C02 chamber has the highest ku value, has different saturation characteristics for neutrons and photons (Maier and Burger, 1978) and can show anomalous characteristics due to gas leakage through the graphite walls (Maier and Burger, 1978; Attix et al., 1978) . Its use is, therefore, not recommended. Results obtained with Mg-Ar chambers also showed inconsistencies, however, and the use of these chambers needs further study (Lewis, 1985) . ku values for nonhydrogenous chambers have been measured by several authors, e.g., Ito (1978b) and Waterman et al. (1979b) . Figure 3 .2 is taken as an example from the latter report and shows the variation of ku with neutron energy. It can be seen from this figure that the ku values increase with neutron energy, largely as a result of the increasing neutron kerma ratio (Km/Kt)n. When using Figure 3 .2 to determine ku at a particular energy, it is necessary to take account of the value of kT shown on the graph by determining the ratio kulkT at the desired energy, and then multiplying this ratio by the value of kT computed with Eq. 3.9.
A dosimeter which has a particularly low ku value is a small Geiger-Muller counter used with a photonenergy compensating filter (see ICRU, 1977, for details) . Measurements of ku for this dosimeter have been reported by several groups (Wagner and Hurst, 1961; ICRU, 1977; Guldbakke et al., 1978; Lewis and Hunt, 1978; Hough, 1979; Klein et al., 1979; Mijnheer et al., 1979; Guldbakke et al., 1980; Jones and McMurray, 1983; Pihet et al., 1982 ). Figure 3.3 (Guldbakke et al., 1980 shows some of the available data for these types of commonly employed GM counters. For the higher-energy neutron beams, kufkT, values for a coihmercially-available counter (ZP-1100) of 3.7 ± 1.0% for p(45) + Be, 4.1 ± 0.4% for d(50) + Be, and 6.1 ± 0.9% for p(66) +Be neutron beams have been observed by Pihet et al. (1982) . GM counters with their energycompensating filters have a high thermal neutron response and should be shielded by a thermal neutron absorber, e.g., 6 Li metal or 6 LiF powder, which does not emit prompt gamma radiation in the neutron cJture process.
It should be recognized that ku for ionization chhers varies with cavity size (e.g., see Makarewicz and Pszona, 1978; and Rubach and Bichsel, 1982b) , and depends on shield design for GM counters (e.g., see Mijnheer et al., 1979) .
Other Dosimetry Methods
Although TE ionization chambers are the most commonly used dosimeters in clinical neutron dosimetry , 1980) . and they are recommended in protocols as the practical method of obtaining total absorbed dose in a TE phantom, other methods of dosimetry can be helpful for certain applications. The accuracy of total absorbed-dose values determined with TE ionization chambers can be checked by comparison with a TE calorimeter. An intercomparison with methods using known fluences and kerma factors will give information on the absolute value of the neutron absorbed dose if the photon absorbed dose is determined separately. Furthermore, small-sized, solid-state dosimeters can be advantageous over a gaseous device for certain purposes, e.g., to check complex treatment techniques in anthropomorphic phantoms and for in vivo dosimetry. General characteristics of these other neutron dosimetry methods and their instrumentation have been discussed in ICRU Report 26 (ICRU, 1977) , whereas more recent developments have been reviewed by Broerse and Mijnheer (1982) . In this Section, some of these techniques, which are of relevance for clinical neutron dosimetry, will be considered. Table 3 .4, which is based on a review compiled by Goodman (1974) , summarizes some of the characteristics.
Absorbed-Dose Measurements
A calorimeter measures the energy deposition in the central element (core). The method is absolute since it does not require a calibration by means of radiation but calibration can be by electrical heating. The appli-cation of A-150 tissue-equivalent plastic calorimeters (Bewley et al., 1974; McDonald et al., 198la, b; Caumes and Simoen, 1984; Caumes et al., 1984) and of a polyethylene calorimeter (Greene and Williams, 1978) in clinical neutron beams, has been reported. Properly designed calorimeters can measure the core temperature rise with minimal heat loss. The main difficulty associated with calorimetric dosimetry is the correction for that portion of the energy deposited by radiation that does not appear as heat (thermal defect). Measurements of McDonald and Goodman (1982) indicate a value of 4.0 ± 1.5% for the thermal defect in A-150 plastic irradiated with fast neutrons. As a result of these accurate measurements of the thermal defect, the uncertainty of the calorimetric determination of the absorbed dose to A-150 plastic for fast neutron beams has been reduced to 1.7% at the 95% confidence level (Caumes and Simoen, 1984) . Calorimetry is, therefore, more accurate than ionization chamber dosimetry, which has a larger overall uncertainty in the determination of absorbed dose to A-150 plastic, if an exposure calibration has been applied. (See Table 3 .2, without the uncertainty in the ratio of neutron kerma.) Calibration of A-150 plastic ionization chambers by means of A-150 plastic calorimeters is, therefore, a more accurate method (see Section 3.1). The absorbed dose to the plastic has to be converted to absorbed dose to tissue for clinical neutron-dosimetry purposes. This will introduce an additional uncertainty into the calorimetric method due to the uncertainty in the kerma ratio of tissue to A-150 plastic. Because this uncertainty in the kerma ratio of ICRU muscle to water is less, a water calorimeter has been used for the direct measurement of the absorbed dose to water in a fast neutron beam (Galloway et al., 1985) . A similar type of water calorimeter has been used in photon beams (e.g., Domen, 1980) . A difference of about 9% in total absorbed dose measured with the water calorimeter and a TE ionization chamber was observed by Galloway et al., if the heat defect in water for photons was also applied for neutrons. Accurate measurements of the thermal defect with neutrons in water will, therefore, be necessary before such a water calorimeter can be used for calibration of ionization in terms of absorbed dose to tissue. Comparisons of the calorimetric and ionometric methods in neutron beams of different energies will be discussed in Section 3.4.
Ionization chambers made from A-150 plastic are recommended for clinical neutron dosimetry. The use of this plastic is a compromise as discussed in Section 3.1 and has several disadvantages. Other plastics for the construction of TE ionization chambers and a matched gas have, therefore, been applied (Sherwin, 1975; Williams, 1985) . The overall uncertainty in absorbed-dose determinations using ionization chambers constructed from alternative materials will, however, not be reduced greatly relative to the use of A-150 ionization chambers. The use of ionization chambers made from other materials provides a partially independent method of measuring absorbed dose and serves as a check on the applied set of physical parameters.
Nonhydrogenous ionization chambers are often Response used in combination with A-150 plastic ionization chambers to determine the photon component of absorbed dose in a neutron field, as discussed in Section 3.2. Characteristics of different types of A-150 plastic and nonhydrogenous ionization chambers have been reviewed elsewhere (CEC, 1980) . The use of low-pressure proportional counters for the investigation of radiation quality has been described in Section 2.2. Measurements with proportional counters having tissue-equivalent (A-150 plastic) or other electrically conductive, e.g., C, Al, or Mg walls, can, however, also be used for an accurate determination of absorbed dose. The counters can be calibrated using an internal alpha particle source. An A-150 plastic proportional counter can also be calibrated in a 60 Co gamma-ray beam, in a way similar to that described in Section 3.2 for ionization chambers (Menzel et al., 1984) . These authors showed that the uncertainty in the determination of the neutron absorbed dose to A-150 plastic using an A-150 plastic proportional counter, calibrated with photons, has about the same value as can be derived for the two-dosimeter method using a TE ionization chamber. In both methods of absorbed-dose determination, the main contribution to the overall uncertainty results from the uncertainty in Wn/Wc and (rm,g)n/[(L/p)m/(L/p)g]c (see Table 3 .2).
An uncertainty of ± 10% in the determination of the gamma-ray absorbed dose using an A-150 plastic or a nonhydrogenous proportional counter has been estimated (Menzel et al., 1984) .
Good spatial resolution in the determination of absorbed dose can be obtained by the use of small solid -state dosimeters. In addition, these systems offer the possibility that they can be exchanged easily through the mail as transfer devices. Besides activation detectors, thermoluminescence dosimeters (TLD) and silicon diodes have been applied for in vivo dosimetry purposes.
TLD can be used either in conjunction with a second dosimeter to determine the gamma-ray contribution to the total absorbed dose, or alone to determine both the neutron and the photon component of the absorbed dose. For the determination of gamma-ray absorbed dose using the two-dosimeter method, it is necessary to know the relative neutron response, ku, of the TLD phosphor. The response of the TLD is partly dependent on the efficiency of different ions in inducing thermoluminescence, which decreases with increasing LET. ku values can be calculated by multiplying the kerma values due to the various charged particles of the neutron reaction in the phosphor by the TL response of that particular ion, after normalization for 60 Co photons. Information on calculated and measured values of ku has increased significantly since publication of the review in ICRU Report 26 (ICRU, 1977) . A more recent survey of experimental data concerning the neutron response of TL materials has been given by Gibson (1985) . He observed large variations in ku values for some TL materials as given by different authors, e.g., a 50% difference for 7 LiF at a neutron energy of about 15 MeV. As discussed by Horowitz (1981) , this could be due to a number of reasons, including the variation in TL response as a function of LET between different batches of dosimeters due to minute variations in impurity concentrations. The neutron response of the TLD material also depends on the atomic composition of the container material, which might explain part of the observed discrepancies, especially at higher neutron energies. TLD systems are good gamma-ray dosimeters for neutron energies up to about 15 MeV, especially if dose rates are too high to use Geiger-Miiller dosimeters. At higher energies, ku values are not well known and might, in addition, be too high to allow accurate gamma-ray determinations in a neutron beam.
The use of TLD for the determination of both neutron and photon absorbed doses is based on the application of different TLD container materials (e.g., Schuhmacher and Krauss, 1978) , the mixture of the phosphor with different materials (e.g., Blum et al., 1976) , and the analysis of the different glow peaks of the TLD material (e.g., Temme et al., 1981; Rassow et al., 1984) . For the first two of these methods, different responses to fast neutrons can be obtained by using either a hydrogenous (situation 1) or a nonhydrogenous (situation 2) material surrounding the phosphor or mixing with the TLD material, respectively. After calibrating the system in a pure gamma-ray field and in a neutron field with known values for the neutron and photon absorbed doses, the system can be employed clinically to determine Dn and D'Y by solving Eq. 3.20 for the two situations: D'u(l) = ku(l)Dn + hu(l)D'Y, D'u(2) = ku(2)Dn + hu(2)D'Y.
(3.21) (3.22) The main disadvantage of these two methods is the strong variation of ku(2) with neutron energy. The neutron response in a phantom, will thus be a function of field size, depth, and position in the field.
The third TLD procedure, described by Temme et al. (1981) , is based on the analysis of a TLD-300 (CaF 2 :Tm) glow curve. The two main peaks in the glow curve show a difference in LET dependence, i.e., have different ku values. This can be used to derive both components in the neutron beam from the irradiation of one detector by solving equations similar to those above. The neutron and photon energy dependence of the system, as determined by Rassow et al. (1985) and Schraube and Weitzenegger (1985) , result in an applicability of the method for mean neutron energies between about 5 and 15 MeV. In this energy range, an uncertainty of about 5% in Dn and D'Y can be achieved, at least up to 20% relative photon absorbed dose (Apostolova et al., 1985) . This correlates to measurements within the beam at phantom depths up to about 20 cm. It can be shown that at higher neutron energies, e.g., for p(65) +Be neutrons, larger uncertainties in Dn and D'Y can be expected by using this method (Apostolova et al., 1985) .
Another approach for deriving separately the neutron and photon absorbed doses is described by Horowitz (1981) and Pradhan and Rassow (1985) , giving a complete discrimination of neutron and photon effects. After exposure of, for instance, CaS04:Dy (TLD-900) pellets to a mixed neutron-photon beam, a first read-out of the phosphor gives information about the sum effect of neutrons and photons. By self-irradiation of the pellets, caused by the beta emission of 32 P produced by neutron activation of the sulfur in the reaction 32 S(n,p)3 2 P, the effect of neutrons alone can be determined. Due to the strong energy dependence of this reaction, the method is not applicable if significant changes in the neutron energy spectrum occur or if a considerable part of the neutrons have energies below about 2 MeV.
Silicon diodes are well suited for in vivo dosimetry; they are small (2-3 mm diameter) and are essentially unaffected by immersion in any but strongly corrosive solutions. The read-out is simple. If proper corrections are introduced to compensate for the fading which occurs between irradiation and read-out and for temperature effects during the read-out, an uncertainty of about 5% can be obtained (Smith et al., 1977; Page and Bewley, 1985) . Smith et al. observed a 16% difference in response for silicon diodes irradiated with d(16) + Be and d(50) +Be neutrons, and expressed the belief that with proper corrections the method can be employed with acceptable accuracy for the neutron energies applied clinically. The results of tests performed with silicon diodes as an in vivo dosimeter are described in Section 3.5.
Photographic films can be used in clinical neutron fields to determine the photon absorbed dose or to map the neutron absorbed-dose distributions. The sensitivity of a photographic emulsion, expressed as an optical density, decreases with increasing LET. A low neutron response, ku, can, therefore, be expected. Measurements of the optical density can thus be used for the assessment of gamma rays in a neutron field. In practice, this can be achieved by using a film with a thin base enclosed in a nonhydrogenous shield. ku values of about 2% have been reported for d + T neutrons for a film covered with a 3-mm thick carbon plate (Hess et al., 1978) . Also, for d(16) + Be neutrons for a film enclosed in a 0.5-mm thick lead sheet (ICRU, 1977) , a ku value of about 2% was observed. Such a lead sheet also corrects for the energy dependence of the photon sensitivity.
Photographic films can be helpful in checking the agreement between the size and position of the neutron beam and optical or mechanical beam localizing devices. In addition, films can be used to determine the beam homogeneity or for checking the position of shielding blocks. This can be done by positioning the film (without any screen) directly in the beam (Dutreix et al., 1978) or by using a transfer method. In the latter method, a distribution of radioactivity is induced in a suitable material, e.g., aluminum plates, by the neutron beam, after which the photographic film is added (Hover and Kronholz, 1981) .
The ferrous sulfate (Fricke) system and lyoluminescence dosimeters have also been proposed as suitable systems for clinical neutron dosimetry, e.g., for transfer systems. The use of ferrous sulfate dosimeters for neutron dosimetry has been described in ICRU Report 26 (ICRU, 1977) . Lyoluminescence dosimetry involves measuring the light emitted when a previously irradiated material is dissolved in a solvent. This technique has been reviewed by Ettinger and Puite (1982) . Both systems are based on reaction products formed by radicals produced in the dosimeter material during irradiation. ku values for both systems show a similar neutron energy dependence and, therefore, can be applied only to determine Dn accurately when the neutron energy distribution is known. A second, neutron insensitive, device will also be necessary. A further disadvantage of both systems is that absorbed-dose values of a few Gy are necessary to obtain a random uncertainty in the measurement of a few percent.
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Kerma Determinations
Neutron kerma can be derived from a neutron fluence determination and a knowledge of the neutron spectrum by the application of fluence-to-kerma conversion factors (kerma factors). A number of methods and instruments to measure neutron fluence, neutron spectra, and kerma have been discussed in I?RU Report 13 (ICRU, 1969) and in Section 2.1 of this report. Detectors based on activation or fission can have a small size and are, therefore, suitable for measurements in vivo and in a phantom in a clinical neutron beam. The principle of obtaining neutron kerma from a set of activation detectors or from 237 Np and 2 ¥U fission chambers has been discussed in ICRU Report 26 (ICRU, 1977) . In the same report, tables with evaluated cross-section data for a number of reactions in the energy range from the thres~old to 18 Me V wer~ givtn. Limited information is available on cross-sect10n values above 20 MeV. Kerma determinations based on activation and fission detection or other neutron fluence measurements will have, therefore, a larger uncertainty in the new higher energy neutron-therapy beam~ than similar measurements carried out at lo1er energies.
Time-of-flight techniques potentially have a hi~h accuracy. The absolute efficiency of the neutron detector can be determined experimentally or calculated by the use of a Monte Carlo code, even for energies extending beyond 20 MeV (see Section 2). However, the method has limited applicability for clinical purpose and is not suitable for measurements in a phantom. The influence of the collimator on the spectral neutron fluence can be taken into account by Monte Carlo calculations (Dietze et al., 1984b) . Scintillation devices can be used to determine the separate neutron and photon energy spectra in a TE phantom (see Section 2.1). Because the uncertainty in the absolute efficiency is rather high, the method is not well-suited for accurate absorbed-dose measurements. In addition to proton recoil measurements, the measurement of the associated alpha particle fluence is used widely for the determination of the neutron fluence of d + T geneirators. The method is, however, only feasible in an open geometry and not in phantoms.
Section 3.4 deals with the intercomparison of neutron kerma values, derived from fluence measu~e ments by using some of the above methods, and neutron absorbed-dose values resulting from other methods.
Dosimetry Intercomparisons
Some standards laboratories are able to provide a calibration service for neutron dosimetry similar to that provided for photon dosimetry, while others are still developing such a service. Furthermore, second-ary standard dosimeters with accurately known characteristics and protocols for the standardization of absorbed-dose measurements for neutron therapy purposes have become available only recently. The need for accurate dosimetry methods is as important for neutron therapy as for photon therapy, to allow an adequate evaluation of clinical results obtained by different groups. A number of dosimetry intercomparisons to compare the dosimetry methods employed by different institutes involved in applications of fast neutrons have been carried out. A comprehensive review of neutron dosimetry intercomparisons performed up to 1976 has been given by Almond and Smathers (1977) , whereas Broerse et al. (1979) also included results of more recent intercomparisons in their summary.
Dosimetry intercomparisons can be divided into two groups: (1) studies primarily intended to compare dosimetry methods using similar or different techniques and (2) intercomparisons of dosimetry systems on which clinical dosimetry has been based in neutron beams actually used for therapy. The first type of intercomparison can be performed in experimentally as well as clinically applied neutron beams. During the International Neutron Dosimetry Intercomparison, INDI (ICRU, 1978a) and the European Neutron Dosimetry Intercomparison Project, ENDIP-1 (Broerse et al., 1978) all participants took their dosimetry systems to a specific experimental site. Both intercomparisons were, therefore, an intercomparison of instrumentation and methods under laboratory conditions and used neutron energies and absorbed-dose rates which differed from those of therapy units. Also, in clinically applied neutron beams, absorbed-dose values, determined with a TE ionization chamber in combination with a neutron insensitive device and derived according to a procedure given in a protocol, have been compared with values obtained from other methods, e.g., calorimetry or fluence measurements. In the second group of intercomparisons, institutions involved in cooperative clinical trials took their reference dosimetry systems to a therapy beam and, where possible, reciprocal visits were made. A link between both groups of intercomparisons was made in the NPL neutron dosimetry intercomparison (Lewis, 1985) . In this intercomparison, standardization laboratories, the ENDIP team as well as radiotherapy institutes participated.
The results of both INDI and END IP were basically the same. The standard deviation in the determinations of the total absorbed dose to ICRU muscle tissue was of the order of 7 to 8 percent. The values reported for the gamma-ray contribution to the absorbed dose showed variations larger than 50%. These variations are not acceptable for radiotherapy since it is generally necessary to know the absorbed dose at an arbitrary point in the target volume in a patient with an overall uncertainty of 5 percent and at the dose specification point with even higher accuracy. Analysis of the results showed that the differences could be attributed to: a. The use of different dosimetry systems, including different types of TE ionization chambers. b. The use of different physical parameters in the determination of absorbed dose from the TE ionization chamber readings (Eqs. 3. 7, 3.9, and 3.17). The values chosen for the ratio of kerma in muscle tissue and in A-150 plastic had, for example, a maximum spread of about 6 percent while values for the displacement correction varied between 0.95 and 1.00. Analysis of the TE ionization chamber data, applying a uniform set of physical parameters, did not, however, improve the agreement between the reported values. c. The use of different measurement procedures.
Apparently the operational characteristics of the ionization chambers during the neutron measurements and the photon calibration, showed systematic differences. The latter is illustrated by the ratios of photon calibration factors of the TE ionization chambers observed at the center of intercomparison and at home, which varied for INDI over a range of about 10% and for ENDIP-1 over a range of about 15% (see Figure 3 .4). McDonald et al. (198la, b) have compared measurements of the absorbed dose to A-150 plastic, determined with TE ionization chambers, to that measured with an A-150 plastic calorimeter in an A-150 plastic phantom using a number of neutron therapy beams. These measurements have shown that, for these neutron beams, the total absorbed dose to A-150 plastic using ionization chambers has a maximum difference of about 2% compared to the same quantity measured using an A-150 plastic calorimeter. Applying either the American or the European protocol for neutron dosimetry for external beam therapy for a d + T beam showed a difference of about 2%, both in good agreement with the value obtained calorimetrically. More recently Caumes et al. (1984) observed in a p(34) + Be beam, a difference of 1.4% between the absorbed dose to A-150 plastic measured with an A-150 plastic calorimeter versus an A-150 plastic ionization chamber applying the European protocol. This lends confidence to the absorbed-dose calculation procedures and data employed as outlined in the protocols. It should be noted, however, that the absorbed dose in tissue will have a larger uncertainty due to the introduction of the ratio of the kerma in tissue to that in A-150 plastic.
Comparisons of neutron kerma obtained from fluence determinations and neutron absorbed dose from TE ionization chamber measurements in combi- (1981c) , also used fission counters as well as activation foils in a collimated d + T beam. Associated alpha particle counting and a proton recoil telescope have been used by Thomas and Lewis (1981) Schlegel-Bickmann et al. (1985) compared these kerma determinations with neutron absorbeddose values obtained from the two-dosimeter method and A-150 plastic proportional counter measurements. The results of these intercomparisons show generally good agreement between the different te~h niques. For these d + T fields and the d(13) + ;Be beam, the different fluence measuring systems gave neutron kerma values which agreed within 2% with TE ionization chamber data.
These intercomparisons, as well as the comparisons with a calorimeter, suggest that the uncertainty in the absorbed-dose determinations with TE ionization chambers might be lower than the overall uncertainty which can be derived from Table 3 .2, at least for energies up to about 14 MeV. At higher neutron energies, larger deviations have been observed. For instance, at a neutron energy of 19 MeV, Jahr et al. (1981) derived a kT value of 0.97 ± 0.06 for their TE ionization chamber, which has to be compared with a value of kT = 0.91 measured by Waterman et al. (1979b) and kT = 1.04 using the recommended data in the European protocol. More recently Schlegel-Bickmann et al. (1985) determined the absorbed dose to A-150 plastic at 19 MeV using the two-dosimeter method and an A-150 plastic proportional counter and observed good agreement. The neutron absorbed-dose values were, however, 11 % lower than the kerma values derived from the fluence data applying the kerma factors of Caswell et al. (1980) . These observations suggest that the differences have to be attributed to uncertainties in the kerma values at these energies, probably in part by assuming too high a cross section (from ENDF/B-r) for the reaction 12 C(n,n'3a) in the kerma factor cal ulations (see Section 3.1.4).
In the second group of intercomparisons carried ut between a limited number of institutions, all using TE ionization chambers, the observed differences were generally smaller than during the INDI and ENDIP intercomparisons. The variations among the data from the participants in the dosimetry intercomparisons in the United States were smaller than in the results obtained among the European groups (Broerse et al., 1979) and in the intercomparisons carried out between American and Japanese groups (Ito, 1978a) . These larger differences were due partly to the use of different types of TE ionization chambers in Europe and Japan, whereas all American groups adopted a common type of chamber. Differences in the photon calibration procedure may result in an additional deviation of about 5% in the measurement of total absorbed dose in a neutron beam (Williams et al., 198f>. It was concluded from the latter type of intercoJ!nparisons, as well as from INDI and ENDIP, that a protocol was needed in which recommendations are given for the measurement procedure including the dosimeter calibration. Such a protocol should, in addition, recommend a consistent set of values for the physical parameters used to convert the dosimeter reading into an absorbed dose value. The introduction of both the American and the European protocol for neutron dosimetry for external beam therapy has reduced considerably the variations in absorbed-dose determinations between different groups. This has been demonstrated, for instance, in the recent EN-D IP-2 intercomparison (Zoetelief and Schraube, 1985) . In this intercomparison, a measuring team visited a number of institutions and compared their absorbed-dose measurements, using the two-dosimeter method, with the values stated by the institution. A maximum deviation of about 2% was observed between local and ENDIP-2 photon calibration factors, which is considerably smaller than the spread observed during the ENDIP-1 intercomparison (see Figure 3.4) . The measurements in the neutron beam showed deviations less than 3% between the total absorbed-dose values measured by the visiting team and the values stated by the institution, again much smaller than observed earlier (see Figure 3 .5). A similar observation was made during the NPL intercomparison (Lewis, 1985) . The adoption of a secondary standard or reference dosimeter and the installation of neutron calibration facilities for such an instrument by national standards laboratories would be the next
